Doximity is a company.
Doximity has raised $82.0M across 3 funding rounds.
Key people at Doximity.
Doximity has raised $82.0M in total across 3 funding rounds.
Key people at Doximity.
Doximity has raised $82.0M in total across 3 funding rounds.
Doximity's investors include Bond, Canvas Ventures, CapitalG, Emergence Capital, First Round Capital, Foundation Capital, ICONIQ Capital, InterWest, Neu Venture Capital, Norwest Venture Partners, Pear VC, Roble Ventures.
Doximity is a leading digital platform and professional network exclusively for U.S. healthcare professionals, including over 80% of physicians, 50% of nurse practitioners (NPs), and physician assistants (PAs).[2][5][6] It provides HIPAA-compliant tools like secure messaging, telehealth (Dialer and Dialer Video), electronic faxing, career management, medical news access, and collaboration features to boost clinician productivity, reduce miscommunication, and improve patient care.[1][3][4][5] Serving more than 2 million verified members, Doximity addresses workflow pain points in healthcare, from clinical coordination to administrative tasks, with rapid adoption rivaling the iPhone among clinicians.[2][6]
The platform monetizes through its clinician-first ecosystem, leveraging its massive network (key resources: IT platform, physician data, brand) to deliver value propositions like secure patient calls without revealing personal numbers, job matching, and AI-enhanced insights in the future.[1][2][5]
Doximity launched in 2010 (with mobile app rollout in 2011) to combat miscommunication and handoff errors in healthcare by enabling secure physician collaboration and HIPAA-compliant tools.[3][5] Founders include CEO Jeff Tangney, who previously built Epocrates (a medical reference app sold successfully), and co-founder Dr. Nate Gross, who started Rock Health, the first digital health venture fund.[2] The idea stemmed from clinicians' need for a "physician-led platform" for workflows, evolving from basic networking to comprehensive tools like Dialer (2016) for masked patient calls and Dialer Video (2020) for telemedicine.[1][5]
Early traction was explosive: by 2014, 40% of U.S. physicians joined; by 2018, over 70% (1 million members); and it hit Deloitte Technology Fast 500 rankings multiple times (e.g., #6 in 2016).[5] Pivotal moments included the 2020 telehealth surge amid COVID-19, with 100,000+ doctors using Dialer Video, and 2023's DocDefender for privacy protection.[5]
Doximity rides the digital transformation of healthcare, capitalizing on telemedicine growth post-COVID, AI integration, and demands for efficient workflows amid clinician shortages and rising admin loads.[1][4] Timing is ideal: launched pre-pandemic but scaled via 2020 video tools, aligning with regulatory shifts favoring virtual care and health equity (e.g., reducing travel emissions).[4][5] Market forces like HIPAA needs, miscommunication risks (causing errors), and tech adoption barriers favor its mobile-first, no-app-required approach over fragmented EMRs.[2][3]
It influences the ecosystem by breaking silos—facilitating nationwide collaboration, referrals, and data-driven insights—while empowering 2M+ pros to deliver higher-quality, lower-friction care, positioning it as a "clinician OS" in a $4T+ U.S. healthcare market.[1][4]
Doximity's dominance (80%+ market penetration) and tool evolution signal sustained leadership, with AI-driven insights, expanded telehealth, and global reach next on horizon amid aging populations and virtual care normalization.[1][4] Trends like health equity mandates, regulatory telehealth support, and AI for diagnostics will amplify growth, potentially evolving it into a full workflow suite influencing payers and hospitals. As the go-to hub transforming clinician productivity, Doximity exemplifies how targeted tech unlocks healthcare's potential.[1][2]
Doximity has raised $82.0M across 3 funding rounds. Most recently, it raised $54.0M Series C in April 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2014 | $54.0M Series C | Bond, Canvas Ventures, CapitalG, Emergence Capital, First Round Capital, Foundation Capital, ICONIQ Capital, InterWest, Neu Venture Capital, Norwest Venture Partners, Pear VC, Roble Ventures, The Perkins Fund, Uncorrelated Ventures, Wildcat Ventures, Dan Ciporin | |
| Sep 1, 2012 | $17.0M Series B | Bond, Canvas Ventures, CapitalG, Emergence Capital, First Round Capital, Foundation Capital, ICONIQ Capital, InterWest, Neu Venture Capital, Norwest Venture Partners, Pear VC, Roble Ventures, The Perkins Fund, Uncorrelated Ventures, Wildcat Ventures, Dan Ciporin | |
| Mar 1, 2011 | $11.0M Series A | Emergence Capital, First Round Capital, ICONIQ Capital, InterWest, Neu Venture Capital, The Perkins Fund, Wildcat Ventures |
